Drug-related mortality among inpatients admitted in Internal Medicine

被引:0
|
作者
Pardo-Cabello, A. J. [1 ]
Manzano-Gamero, V [2 ]
Del-Pozo, E. [3 ]
Gomez-Jimenez, F. J. [4 ]
Luna-del Castillo, J. D. [5 ]
Puche-Canas, E. [6 ]
机构
[1] Hosp Clin San Cecilio, Serv Med Interna, Ave Invest S-N, Granada 18016, Spain
[2] Hosp Univ Virgen de las Nieves, Serv Med Interna, Granada, Spain
[3] Univ Granada, Inst Invest Biomed IBS, Fac Med, Dept Farmacol, Granada, Spain
[4] Univ Granada, Fac Med, Dept Med, Granada, Spain
[5] Univ Granada, Fac Med, Dept Bioestadist, Granada, Spain
[6] Univ Granada, Fac Med, Dept Farmacol, Granada, Spain
关键词
Adverse drug reactions; Hospital mortality; Internal Medicine; Pharmacoepidemiology; EVENTS; DEATHS;
D O I
10.23938/ASSN.0381
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background. To analyze the mortality associated with prescriptions, the drugs most frequently involved and the associated risk factors in patients admitted to Internal Medicine. Methods. A retrospective, observational study The clinical records of adult patients who died consecutively in the department of Internal Medicine in a Spanish tertiary hospital over twenty-two months were reviewed. The main variable was the prevalence of hospital death suspected of being related to the medications administered during admission. Results. Out of the 455 deaths analyzed, 22.2% were related to the medications received; in 55 cases (12.1%) the drugs were suspected of being the cause of death and in 46 cases (10.1%) of contributing to it The most frequent diagnoses in cases of death associated with drugs were cardiac arrhythmia (23.7%), severe hemorrhage (19.8%) and aspiration pneumonia (12.8%). The drugs with the highest prevalence in deaths related to pharmacological treatment were antithrombotic drugs (23.7%), digoxin (21.7%), antipsychotics (17.8%) and benzodiazepines (14.8%). The only independent risk factor for mortality associated with treatment was the number of medications administered (OR=1.25, 95%CI: 1.14-1.37). No significant association was found with age, sex, number of pathologies or duration of hospital stay. Conclusion. A high percentage of deaths of patients admitted to Internal Medicine were considered related to the medications received. Antithrombotic drugs, digoxin and psychotropic drugs were the agents most frequently implicated. This mortality is independently and significantly associated with the number of medications administered.
引用
收藏
页码:339 / 346
页数:8
相关论文
共 50 条
  • [1] Drug-related mortality among inpatients: a retrospective observational study
    Pardo Cabello, Alfredo Jose
    Del Pozo Gavilan, Esperanza
    Gomez Jimenez, Francisco Javier
    Mota Rodriguez, Carmen
    de Dios Luna Del Castillo, Juan
    Puche Canas, Emilio
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 72 (06) : 731 - 736
  • [2] Drug-related mortality among inpatients: a retrospective observational study
    Alfredo José Pardo Cabello
    Esperanza Del Pozo Gavilán
    Francisco Javier Gómez Jiménez
    Carmen Mota Rodríguez
    Juan de Dios Luna Del Castillo
    Emilio Puche Cañas
    European Journal of Clinical Pharmacology, 2016, 72 : 731 - 736
  • [3] DRUG-RELATED PROBLEMS PRIOR TO HOSPITALIZATION ON INTERNAL MEDICINE WARDS
    Draganov, Ivana
    Drndarevic, Aneta
    Kovacevic, Milena
    Miljkovic, Branislava
    Vuksanovic, Miljanka
    Jankovic, Aleksandar
    Kalaba, Ana
    Kovacevic, Sandra vezmar
    ACTA POLONIAE PHARMACEUTICA, 2024, 81 (01): : 145 - 154
  • [4] Prevalence and risk factors of drug-related hospitalizations in multimorbid patients admitted to an internal medicine ward
    Lea, Marianne
    Mowe, Morten
    Mathiesen, Liv
    Kvernrod, Kristin
    Skovlund, Eva
    Molden, Espen
    PLOS ONE, 2019, 14 (07):
  • [5] Drug-related deaths in hospital inpatients: A retrospective cohort study
    Montane, Eva
    Arellano, Ana Lucia
    Sanz, Yolanda
    Roca, Josep
    Farre, Magi
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 84 (03) : 542 - 552
  • [6] Drug-related problems identification in general internal medicine: The impact and role of the clinical pharmacist and pharmacologist
    Guignard, Bertrand
    Bonnabry, Pascal
    Perrier, Arnaud
    Dayer, Pierre
    Desmeules, Jules
    Samer, Caroline Flora
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2015, 26 (06) : 399 - 406
  • [7] Estimated Costs of Drug-Related Problems Prevented by Pharmacist Prescription Reviews Among Hospitalized Internal Medicine Patients
    Zheng, Xiaoying
    Shan, Xuefeng
    Liu, Weichu
    Gao, Diansa
    Jiang, Huiming
    Xue, Lifen
    Hu, Lei
    Qiu, Feng
    QUALITY MANAGEMENT IN HEALTH CARE, 2024, 33 (02) : 86 - 93
  • [8] Cost of Prescription Drug-Related Morbidity and Mortality
    Watanabe, Jonathan H.
    McInnis, Terry
    Hirsch, Jan D.
    ANNALS OF PHARMACOTHERAPY, 2018, 52 (09) : 829 - 837
  • [9] Systematic Review of Risk Factors Assessed in Predictive Scoring Tools for Drug-Related Problems in Inpatients
    Jung-Poppe, Lea
    Nicolaus, Hagen Fabian
    Roggenhofer, Anna
    Altenbuchner, Anna
    Dormann, Harald
    Pfistermeister, Barbara
    Maas, Renke
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (17)
  • [10] Drug-related interventions made through a computerized prescription order entry system in an Internal Medicine Unit
    Duran Garcia, M. E.
    Perez Sanz, C.
    Jimenez Munoz, A. B.
    Gimenez Manzorroa, A.
    Muino Miguez, A.
    Alvarez-Sala Walter, L. A.
    Sanjurjo Saez, M.
    REVISTA CLINICA ESPANOLA, 2009, 209 (06): : 270 - 278